| mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.9 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |